Evidence for superantigen involvement in preeclampsia

American Journal of Reproductive Immunology

Volumn 43, Issue 4, 2000, Pages 187-196

  Luppi, Patrizia ^a   Mcknight, Craig ^b   Mathie, Thomas ^a   Faas, Susan ^a   Rudert, William A ^a   Stewart Akers, Ann M ^b   Trucco, Massimo ^a   Deloia, Julie A ^b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Immunology; Placenta; Pregnancy; T cell receptor

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HLA TYPING; HUMAN; IMMUNE SYSTEM; MATERNAL MORBIDITY; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL;

EID: 0034058577     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.8755-8920.2000.430401.x     Document Type: Article

References (55)

1. Villar MA, Sibai BM: Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during pregnancy. Am J Obstet Gynecol 1989; 160:419-423.
2. Roberts JM, Redman CWG: Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341:1447-1451.
3. Spargo BH, Lichtig C, Luger AM, Katz AI, Lindheimer MD: The renal lesion in preeclampsia. Perspectives Neprol Hypertens 1976; 5:129-137.
4. Cooper DW, Hill JA, Chesley LC, Bryans CI: Genetic control of susceptibility to eclampsia and miscarriage. Br J Obstet Gynaecol 1988; 95:644-653.
5. Thornton JG, Onwude JL: Pre-eclampsia: Discordance among identical twins. BMJ 1991; 303:1241-1242.
6. Zhou YC, Damsky CH, Chiu K, Roberts JM, Fisher SJ: Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993; 91:950-960.
7. Zhou Y, Damsky CH, Fisher SJ: Preeclampsia is associated with failure of human cytotrophoblast to mimic a vascular phenotype. One cause of defective endovascular invasion of this syndrome? J Clin Invest 1997; 99:2152-2164.
8. Houser MT, Fish AJ, Tagatz GE, Williams PP, Michael AF: Pregnancy and systemic lupus erythematosus. Am J Obstet Gynecol 1980; 138:409-413.
9. Feeney JG, Tovey LA, Scott JS: Influence of previous blood-transfusion on incidence of pre-eclampsia. Lancet 1977; 1:874-875.
10. Klonoff-Cohen HS, Savitz DA, Cefalo RC, McCann MF: An epidemiologic study of contraception and preeclampsia. JAMA 1989; 262:3143-3147.
11. Robillard PY, Husley TC, Alexander GR, Keenan A, de Caunes F, Papiernik E: Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol 1993; 24:1-12.
12. Dekker GA: Oral tolerization to paternal antigens and preeclampsia. Am J Obstet Gynecol 1996; 174:450.
13. Matthiesen L, Berg G, Ernerudh J, Skogh T: Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Am J Reprod Immunol 1995; 33:31-39.
14. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW: Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102:20-25.
15. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH: Tumor necrosis factor-alpha (TNF-α) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104:154-159.
16. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol M: Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170:1752-1759.
17. Conrad KP, Miles TM, Benyo DF: Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998; 40:102-111.
18. Hara N, Fugii T, Okai T, Taketani Y: Histochemical demonstration of interleukin-2 in decidua cells of patients with preeclampsia. Am J Reprod Immunol 1995; 34:44-51.
19. Kitzmiller JL, Benirschke K: Immunofluorescent study of placental bed vessels in preeclampsia of pregnancy. Am J Obstet Gynecol 1973; 115:248-251.
20. Branch WD, Andres R, Digre KB, Rote NS, Scott JR: The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73:541-545.
21. Milliez J, Lelong F, Bayani N, Jannet D, el Medjadji M, Latrous H, Hammami M, Paniel BJ: The prevalence of auto-antibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. Am J Obstet Gynecol 1991; 165:51-56.
22. Marrack P, Kappler JW: The staphylococcal enterotoxins and their relatives. Science 1990; 248:705-711.
23. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, Scott-Algara D: Evidence for a viral superantigen in humans. Nature 1992; 358:507-510.
24. Dobrescu D, Ursea B, Pope M, Asch AS, Posnett DN: Enhanced HIV-1 replication in Vβ12 T cells due to human cytomegalovirus in monocytes: Evidence for a putative herpesvirus superantigen. Cell 1995; 82:753-763.
25. Acha-Orbea H, Palmer E: Mls-retrovirus exploits the immune system. Immunol Today 1991; 12:356-361.
26. Luppi P, Trucco M: Superantigens in insulin-dependant diabetes mellitus. In Seminars in Immunopathology, HR MacDonald (ed.), vol. 17. Heidelberg, Germany, Springer International, 1996, pp 333-362.
27. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994; 368:711-713.
28. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P: The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56:27-35.
29. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Finegold D, Trucco M: Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371:351-355.
30. Luppi P, Rudert WA, Zanone MM, Stassi G, Trucco G, Finegold D, Boyle GJ, Del Nido P, McGowan Jr FX, Trucco M: Idiopathic dilated cardiomyopathy: A superantigen-driven autoimmune disease. Circulation 1998; 98:777-785.
31. Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M: The T cell receptor Vβ usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma. Cancer Res 1992; 52:5913-5920.
32. Faas SJ, Menon R, Braun ER, Rudert WA, Trucco M: Sequence-specific priming and exonuclease-released fluorescence detection of HLA-DQB1 alleles. Tissue Antigens 1996; 48:97-112.
33. Rudert WA, Braun ER, Faas SJ, Menon R, Jaquins-Gerstl A, Trucco M: Double-labeled fluorescent probes for 5′ nuclease assays: Purification and performance evaluation. BioTechniques 1997; 22:1140-1145.
34. Menon R, Rudert WA, Braun E, Jaquins-Gerstl A, Faas SJ, Trucco M: Sequence-specific priming and exonuclease-released fluorescence assay for a rapid and reliable HLA-A molecular typing. Mol Med 1997; 2:99-111.
35. Jorgensen JL, Esser U, Fazekas de St. Groth B, Reay PA, Davis MM: Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 1992; 355:224-230.
36. Pannetier C, Even J, Kourilsky P: T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16:176-181.
37. Manfras BJ, Rudert WA, Trucco M, Boehm BO: Analysis of the α/β T-cell receptor repertoire by competitive and quantitative family-specific PCR with exogenous standards and high resolution fluorescence based CDR3 size imaging. J Immunol Methods 1997; 210:235-249.
38. Tsuji K, Aizawa M, Sasazuki T (eds): HLA 1991; Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford, Oxford Science Publications, 1992.
39. Toder V, Blank M, Gleicher N, Voljovich I, Mashiah S, Nebel L: Activity of natural killer cells in normal pregnancy and edema-proteinuria-hypertension gestosis. Am J Obstet Gynecol 1983; 145:7-10.
40. Greer IA, Dawes J, Johnson TA, Calder AA: Neutrophil activation is confined to the maternal circulation in pregnancy-induced-hypertension. Obstet Gynecol 1991; 78:28-32.
41. Berge LN, Ostensen M, Revhaug A: Phagocytic cell activity in preeclampsia. Acta Obstet Gynecol Scand 1988; 67:499-504.
42. Greer IA, Lyall F, Perera T, Boswell F, Macara LM: Increased concentration of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction? Obstet Gynecol 1994; 84:937-940.
43. Meekins JW, McLaughlin PJ, West DC, McFadyen IR, Johnson PM: Endothelial cell activation by tumor necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia. Clin Exp Immunol 1994; 98:110-114.
44. Leung DYM, Collins T, LaPierre LA, Geha RS, Pober JS: Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986; 77:1428-1435.
45. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL: Evidence for the effects of a superantigen in rhematoid arthritis. Science 1991; 25:325-329.
46. Choi Y, Lafferty JA, Clements JR, Todd JK, Gelfand EW, Kappler J, Marrack P, Kotzin BL: Selective expansion of T cells expressing Vβ2 in Toxic Shock Syndrome. J Exp Med 1990; 172:981-984.
47. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DYM: Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 1992; 89:4066-4077.
48. Tanabe T, Torres BA, Subramaniam PS, Johnson HM: Vβ activation by HIV Nef protein: Detection by a simple amplification procedure. Biochem Biophys Res Commun 1997; 230:509-513.
49. Cole BC, Balderas RA, Ahmed EA, Kono D, Theofilopoulos AN: Genomic composition and allelic polymorphisms influence Vβ usage by the mycoplasma arthritidis superantigen. J Immunol 1993; 150:3291-3299.
50. Subramanyam M, McLellan B, Labrecque N, Sekaly RP, Hubert BT: Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. J Immunol 1993; 151:2538-2545.
51. Nagelkerken L, Gollob KJ, Tielemans M, Coffman RL: Role of transforming growth factor-β in the preferential induction of T helper cells to type 1 by staphylococcal enterotoxin. Eur J Immunol 1993; 23:2306-2310.
52. Fast DJ, Schlievert PM, Nelson RD: Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun 1989; 57:291-294.
53. Woodland DW, Wen R, Blackman MA: Why do superantigens care about peptides? Immunol Today 1997; 18:18-22.
54. Takakuwa K, Arakawa M, Tamura M, Hataya I, Higashino M, Yasuda M, Tanaka K: HLA antigens in patients with severe preeclampsia. J Perinatal Med 1997; 25:79-83.
55. Kilpatrick DC:: HLA-dependent TNF secretory response may provide an immunogenetic link between pre-eclampsia and type 1 diabetes mellitus. Disease Markers 1996; 13:43-47.